Full text is available at the source.
The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein
Low-glycemic-index diet in type 2 diabetes lowers inflammation but does not change blood sugar control after one year
AI simplified
Abstract
A low-glycemic index (GI) diet resulted in a 30% lower C-reactive protein level compared to a high-GI diet.
- Body weight and long-term glycated hemoglobin (HbA1c) levels did not significantly differ among the high-GI, low-GI, and low-carbohydrate diets.
- Fasting glucose levels were higher after 12 months on the low-GI diet, while 2-hour post-load glucose levels were lower.
- The low-GI diet led to a 12% increase in overall mean triacylglycerol and a 4% decrease in HDL cholesterol compared to the low-carbohydrate diet.
- The difference in the ratio of total to HDL cholesterol among the diets disappeared by 6 months.
- The low-GI diet was associated with a 30% reduction in C-reactive protein compared to the high-GI diet.
AI simplified